On the other hand, vessel-targeted therapeutic strategies are designed to interfere with the vasculature of tumors to inhibit tumor growth and the strategies developed to inhibit tumor neovascularization have provided therapeutic benefits, including inhibition of vascular endothelial growth factor (VEGF) or tyrosine kinases3. Here, VEGFA is linked to neoplasm.